Načítá se...
Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
BACKGROUND: This study investigated the therapeutic effects of the peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone in ob/ob mice with obesity-related glomerulopathy (ORG). MATERIAL/METHODS: A total of 24 mice were divided into 3 groups: wild-type C57BL/6 mice (n=8), ob/ob m...
Uloženo v:
| Vydáno v: | Med Sci Monit |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Scientific Literature, Inc.
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6407328/ https://ncbi.nlm.nih.gov/pubmed/30820023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.913461 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|